ARTIVION INC (AORT) Stock Price, Forecast & Analysis
USA - NYSE:AORT - US2289031005 - Common Stock
AORT Key Statistics, Chart & Performance
The current stock price of AORT is 44.87 USD. In the past month the price increased by 11.62%. In the past year, price increased by 56.29%.
AORT Latest News, Press Relases and Analysis
AORT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.32 | 219.92B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.04 | 200.75B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.91 | 148.20B | ||
| SYK | STRYKER CORP | 27.03 | 136.11B | ||
| IDXX | IDEXX LABORATORIES INC | 56.18 | 56.68B | ||
| BDX | BECTON DICKINSON AND CO | 12.33 | 50.97B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.45 | 48.96B | ||
| RMD | RESMED INC | 25.4 | 36.70B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.92 | 33.35B | ||
| PODD | INSULET CORP | 69.98 | 22.51B | ||
| DXCM | DEXCOM INC | 29.57 | 21.57B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.94 | 17.53B |
Related stock screener links
About AORT
Company Profile
Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company is headquartered in Kennesaw, Georgia and currently employs 1,600 full-time employees. The firm is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
Company Info
ARTIVION INC
1655 Roberts Boulevard N W
Kennesaw GEORGIA US
Employees: 1600
Phone: 17704193355
ARTIVION INC / AORT FAQ
Can you describe the business of ARTIVION INC?
Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company is headquartered in Kennesaw, Georgia and currently employs 1,600 full-time employees. The firm is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
Can you provide the latest stock price for ARTIVION INC?
The current stock price of AORT is 44.87 USD. The price decreased by -5.54% in the last trading session.
What is the dividend status of ARTIVION INC?
AORT does not pay a dividend.
What is the ChartMill technical and fundamental rating of AORT stock?
AORT has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is the employee count for AORT stock?
ARTIVION INC (AORT) currently has 1600 employees.
What is ARTIVION INC worth?
ARTIVION INC (AORT) has a market capitalization of 2.12B USD. This makes AORT a Mid Cap stock.
Can you provide the short interest for AORT stock?
The outstanding short interest for ARTIVION INC (AORT) is 3.12% of its float.
AORT Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to AORT. When comparing the yearly performance of all stocks, AORT is one of the better performing stocks in the market, outperforming 89.42% of all stocks.
AORT Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to AORT. AORT has only an average score on both its financial health and profitability.
AORT Financial Highlights
Over the last trailing twelve months AORT reported a non-GAAP Earnings per Share(EPS) of -0.26. The EPS decreased by -85.71% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2.13% | ||
| ROE | -4.26% | ||
| Debt/Equity | 0.52 |
AORT Forecast & Estimates
13 analysts have analysed AORT and the average price target is 46.16 USD. This implies a price increase of 2.88% is expected in the next year compared to the current price of 44.87.
For the next year, analysts expect an EPS growth of 126.16% and a revenue growth 11.67% for AORT